Carlyle and SK Capital Acquire bluebird bio

H.I.G. Capital Makes Equity Investment in The Bluebird Group

August 9, 2021

Marketing & Advertising

An affiliate of H.I.G. Capital has made an equity investment in The Bluebird Group, a Minneapolis-based retail services and consulting firm. The investment will support Bluebird's expansion and development of next-generation digital insights and analytics to enhance services for consumer brands.

Carlyle Acquires Abingworth to Expand Global Healthcare & Life Sciences Investing

August 3, 2022

Healthcare Services

Global investment firm Carlyle has acquired Abingworth, a transatlantic life sciences investment firm with about $2 billion in assets under management, to broaden Carlyle's healthcare franchise and capabilities across venture to buyouts. The deal brings Abingworth's specialized team and clinical co-development expertise into Carlyle and establishes Launch Therapeutics, an operating company to accelerate late-stage clinical development; terms were not disclosed.

Carlyle Leads Majority Growth Investment in Saama Technologies

October 20, 2021

AI & Machine Learning

Global investment firm Carlyle led a strategic growth investment of up to $430 million to acquire a majority stake in Saama Technologies. A syndicate of healthcare-focused investors — including Amgen Ventures, Intermountain Ventures, Merck Global Health Innovation Fund, McKesson Ventures, Northpond Ventures, Pfizer Ventures and Population Health Partners — will co-invest to accelerate Saama's AI-driven Life Science Analytics Cloud and expand go-to-market and R&D capabilities.

cbdMD Acquires Substantially All Assets of Bluebird Botanicals

January 29, 2026

Consumer Products

cbdMD, Inc. (NYSE American: YCBD) acquired substantially all assets of Bluebird Botanicals in early January 2026 to integrate Bluebird's regulatory science, safety and IP assets into cbdMD's clinical and toxicology platform. The deal strengthens cbdMD's regulatory-compliance and GRAS capabilities for both broad-spectrum and full-spectrum cannabinoid formulations and is expected to contribute to revenue growth and expanded product safety dossiers.

Carlyle Acquires $415M Private Student Loan Portfolio and Invests in Monogram

January 24, 2024

Financial Services

The Carlyle Group, via its Credit Strategic Solutions team, acquired a $415 million private student loan portfolio and made a strategic investment in Monogram LLC to partner on originating, acquiring and managing private student loan assets. Monogram — led by the former Cognition Financial management team and headquartered in Boston — will leverage Carlyle's capital to expand its origination, servicing and portfolio management capabilities.

Carlyle Acquires Majority Stake in Sciens Building Solutions

November 9, 2021

Industrial Services

Funds managed by global investment firm Carlyle acquired a majority stake in Sciens Building Solutions from Huron Capital, with Sciens' senior management and Huron retaining minority equity and a board seat. The investment will support Sciens' growth strategy — accelerating organic investment and M&A to expand its fire and life safety platform across commercial, institutional and government end markets. Terms were not disclosed.